Tonix Pharmaceuticals Holding Corp. (TNXP)
12.45
-0.10
(-0.80%)
USD |
NASDAQ |
Aug 24, 16:00
12.43
-0.02
(-0.16%)
After-Hours: 20:00
Tonix Pharmaceuticals Shareholders Equity (Quarterly) : 222.28M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 222.28M |
| March 31, 2026 | 227.14M |
| December 31, 2025 | 245.15M |
| September 30, 2025 | 231.14M |
| June 30, 2025 | 168.00M |
| March 31, 2025 | 180.40M |
| December 31, 2024 | 139.56M |
| September 30, 2024 | 74.21M |
| June 30, 2024 | 42.10M |
| March 31, 2024 | 108.14M |
| December 31, 2023 | 105.52M |
| September 30, 2023 | 120.83M |
| June 30, 2023 | 140.46M |
| March 31, 2023 | 165.43M |
| December 31, 2022 | 207.18M |
| September 30, 2022 | 228.92M |
| June 30, 2022 | 259.78M |
| March 31, 2022 | 207.96M |
| December 31, 2021 | 218.72M |
| September 30, 2021 | 202.22M |
| June 30, 2021 | 180.49M |
| March 31, 2021 | 176.92M |
| December 31, 2020 | 87.65M |
| September 30, 2020 | 62.57M |
| June 30, 2020 | 53.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 31.25M |
| December 31, 2019 | 9.417M |
| September 30, 2019 | 9.855M |
| June 30, 2019 | 12.82M |
| March 31, 2019 | 17.81M |
| December 31, 2018 | 23.66M |
| September 30, 2018 | 13.71M |
| June 30, 2018 | 15.84M |
| March 31, 2018 | 18.61M |
| December 31, 2017 | 24.62M |
| September 30, 2017 | 28.68M |
| June 30, 2017 | 33.97M |
| March 31, 2017 | 21.98M |
| December 31, 2016 | 25.36M |
| September 30, 2016 | 27.10M |
| June 30, 2016 | 30.03M |
| March 31, 2016 | 27.34M |
| December 31, 2015 | 40.26M |
| September 30, 2015 | 52.65M |
| June 30, 2015 | 46.24M |
| March 31, 2015 | 56.89M |
| December 31, 2014 | 36.09M |
| September 30, 2014 | 43.78M |
| June 30, 2014 | 42.66M |
| March 31, 2014 | 47.92M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis, Inc. | 1.844B |
| Inovio Pharmaceuticals, Inc. | 4.371M |
| Heron Therapeutics, Inc. | 6.908M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 254.09M |
| Total Liabilities (Quarterly) | 31.81M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 6.608 |
| Net Debt Paydown Yield | -0.07% |